Manufacturing CFOs Prioritize Tech Talent and Tariffs in 2026 Says Forvis Mazars Standard Chartered Targets Higher Returns With Over 15 Reduction in Corporate Functions Roles by 2030 Fed Rate Hike Expectations for 2026 Key Market Factors Investors Should Watch South Koreas Galaxy Robot Park Aims to Merge KPop and Robotics to Redefine Entertainment Tourism Embecta Faces Aggressive Target Cut Amid Broader Medtech Sector Weakness Centres Ebola Travel Advisory May Impact Aviation and Pharma Sentiment ELS Q1 2026 Earnings Modest EPS Beat Amid Stable Operations CCM Q2 2016 Earnings Misses EPS Estimates by Wide Margin WWW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Brand Strength PRHIZ Q1 2024 Earnings Strong EPS Surprise Revenue Not Disclosed STKS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Headwinds Under Armour UA Q1 2026 Earnings EPS Misses by 695 Stock Edges Higher Inventiva SA IVA Slides 269 as Biotech Sentiment Sours Northrim BanCorp NRIM Climbs Modestly as Shares Test Key Resistance Zone Citius Oncology Inc CTOR Slips 926 as Price Tests Key Support at 077 Armata Pharmaceuticals ARMP Slides 245 Approaching Key Support as Selling Pressure Mounts Redwood Trust Senior Notes RWTP Slide Marginally as Yield Attracts Cautious Traders Precigen Inc PGEN Holds Steady at 424 as Stock Nears Key Support Level iHuman Inc IH Edges Higher as Stock Tests Key Resistance Near 172 Stratus Properties STRS Edges Lower as Stock Tests Key Support Levels Alnylam Pharmaceuticals ALNY Gains 319 as Biotech Sector Momentum Builds Atrium Therapeutics RNA Drops Slightly Amidst Market Caution Holds Above Support Purple Biotech PPBT Edges Higher Modest Uptick Faces Resistance at 304 GMs AllElectric Cadillac Vistiq A New Luxury EV With 300Mile Range CWD Q1 2026 Earnings Major EPS Miss Highlights Operational Difficulties Blackrock MuniYield New York Quality Fund MYN Edges Higher Approaching 10 Resistance